Suppr超能文献

淋巴结库:生理学、HIV 感染和抗逆转录病毒治疗。

The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.

机构信息

Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina, USA.

School of Medicine, The University of North Carolina, Chapel Hill, North Carolina, USA.

出版信息

Clin Pharmacol Ther. 2021 Apr;109(4):918-927. doi: 10.1002/cpt.2186. Epub 2021 Feb 28.

Abstract

Despite advances in treatment, finding a cure for HIV remains a top priority. Chronic HIV infection is associated with increased risk of comorbidities, such as diabetes and cardiovascular disease. Additionally, people living with HIV must remain adherent to daily antiretroviral therapy, because lapses in medication adherence can lead to viral rebound and disease progression. Viral recrudescence occurs from cellular reservoirs in lymphoid tissues. In particular, lymph nodes are central to the pathology of HIV due to their unique architecture and compartmentalization of immune cells. Understanding how antiretrovirals (ARVs) penetrate lymph nodes may explain why these tissues are maintained as HIV reservoirs, and how they contribute to viral rebound upon treatment interruption. In this report, we review (i) the physiology of the lymph nodes and their function as part of the immune and lymphatic systems, (ii) the pathogenesis and outcomes of HIV infection in lymph nodes, and (iii) ARV concentrations and distribution in lymph nodes, and the relationship between ARVs and HIV in this important reservoir.

摘要

尽管在治疗方面取得了进展,但找到治愈 HIV 的方法仍是当务之急。慢性 HIV 感染与合并症的风险增加有关,如糖尿病和心血管疾病。此外,HIV 感染者必须坚持每日接受抗逆转录病毒治疗,因为药物依从性的下降会导致病毒反弹和疾病进展。病毒的复发来自于淋巴组织中的细胞储库。特别是,淋巴结由于其独特的结构和免疫细胞的分区化,是 HIV 病理学的核心。了解抗逆转录病毒药物 (ARV) 如何穿透淋巴结,可以解释为什么这些组织被维持为 HIV 储库,以及它们在治疗中断时如何导致病毒反弹。在本报告中,我们回顾了(i)淋巴结的生理学及其作为免疫和淋巴系统一部分的功能,(ii)HIV 在淋巴结中的发病机制和结果,以及(iii)淋巴结中 ARV 的浓度和分布,以及 ARV 和 HIV 在这个重要储库中的关系。

相似文献

1
The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.
Clin Pharmacol Ther. 2021 Apr;109(4):918-927. doi: 10.1002/cpt.2186. Epub 2021 Feb 28.
2
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148.
4
Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?
J Infect Dis. 2024 Mar 14;229(3):635-643. doi: 10.1093/infdis/jiad381.
5
Antihelminthics in helminth-endemic areas: effects on HIV disease progression.
Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD006419. doi: 10.1002/14651858.CD006419.pub4.
6
Accuracy of measures for antiretroviral adherence in people living with HIV.
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD013080. doi: 10.1002/14651858.CD013080.pub2.
8
Therapeutic drug monitoring of antiretrovirals for people with HIV.
Cochrane Database Syst Rev. 2009 Jul 8(3):CD007268. doi: 10.1002/14651858.CD007268.pub2.
9
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Cochrane Database Syst Rev. 2014 May 22;2014(5):CD004772. doi: 10.1002/14651858.CD004772.pub4.
10
Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005482. doi: 10.1002/14651858.CD005482.

引用本文的文献

3
Intracellular Penetration of Atazanavir, Ritonavir and Dolutegravir With Concomitant Rifampicin: A Dose Escalation Study.
Clin Pharmacol Ther. 2025 May;117(5):1393-1402. doi: 10.1002/cpt.3572. Epub 2025 Jan 31.
4
Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors.
Cell Rep. 2025 Jan 28;44(1):115202. doi: 10.1016/j.celrep.2024.115202. Epub 2025 Jan 10.
5
Melanoma in people living with HIV: Immune landscape dynamics and the role of immuno- and antiviral therapies.
Cancer Metastasis Rev. 2024 Nov 29;44(1):9. doi: 10.1007/s10555-024-10230-6.
7
HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence.
Health Sci Rep. 2024 Sep 23;7(9):e70089. doi: 10.1002/hsr2.70089. eCollection 2024 Sep.
8
Post-Transcriptional HIV-1 Latency: A Promising Target for Therapy?
Viruses. 2024 Apr 24;16(5):666. doi: 10.3390/v16050666.

本文引用的文献

1
An Integrated Spatial Dynamics-Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes.
Front Bioeng Biotechnol. 2020 Jun 26;8:667. doi: 10.3389/fbioe.2020.00667. eCollection 2020.
3
Mass Spectrometry Imaging Demonstrates the Regional Brain Distribution Patterns of Three First-Line Antiretroviral Drugs.
ACS Omega. 2019 Dec 5;4(25):21169-21177. doi: 10.1021/acsomega.9b02582. eCollection 2019 Dec 17.
5
HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.
J Clin Invest. 2019 Jul 30;129(11):4629-4642. doi: 10.1172/JCI126714.
6
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.
Nat Commun. 2019 Jul 19;10(1):3193. doi: 10.1038/s41467-019-10884-9.
7
Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species.
Sci Transl Med. 2019 Jul 3;11(499). doi: 10.1126/scitranslmed.aap8758.
10
Clones of infected cells arise early in HIV-infected individuals.
JCI Insight. 2019 Jun 20;4(12). doi: 10.1172/jci.insight.128432.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验